RAB15: A Brain-Enriched GTPase Regulating Endocytic and Exocytic Trafficking

Introduction

RAB15 (UniProt: P59190) is a member of the Rab family of small GTPases within the Ras superfamily, functioning as a molecular switch that regulates intracellular membrane trafficking in human cells. The human RAB15 gene (NCBI Gene ID: 376267) is located on chromosome 14q23.3 and spans approximately 26.5 kb with 8 exons, encoding a 212-amino acid protein that acts primarily at the interface between early/sorting endosomes and the endocytic recycling compartment (ERC), playing a regulatory role in receptor-mediated endocytosis and recycling pathways [zuk-1999-rab15-early-endocytic-abstract]. RAB15 possesses intrinsic GTPase activity (EC 3.6.5.2) and cycles between an active GTP-bound state and an inactive GDP-bound state, with this conformational switching determining its capacity to recruit downstream effector proteins [hutagalung-2011-rab-review-abstract].

Unlike many other Rab GTPases that stimulate membrane trafficking, RAB15 appears to function primarily as an inhibitory regulator of early endocytic events. This distinctive regulatory property, combined with its tissue-enriched expression pattern in the brain, positions RAB15 as a specialized component of endocytic machinery with potential relevance to neuronal function and neurodevelopmental processes [zuk-2000-rab15-differential-abstract]. More recently, RAB15 has been recognized to have a dual role, participating not only in endocytosis but also in regulated exocytosis of specialized secretory organelles called Weibel-Palade bodies in endothelial cells [zografou-2012-wpb-exocytosis-abstract]. The protein has attracted particular interest in the context of neuroblastoma biology, where altered RAB15 expression and alternative splicing patterns correlate with differentiation state and tumor-initiating cell phenotypes [nishimura-2011-rab15-retinoic-acid-abstract; pham-2012-rab15-splicing-abstract].

From an evolutionary perspective, RAB15 emerged as part of a set of Rab duplications specific to metazoans, along with Rab3, Rab10, Rab26, Rab27, Rab34, and several others. These Rab families expanded further in vertebrates, and RAB15 orthologs are conserved across mammals. RAB10 represents an important paralog, while orthologs are absent in yeast species such as Eremothecium gossypii and Kluyveromyces lactis, indicating that RAB15 evolved to support specialized trafficking functions in multicellular organisms [ncbi-gene-rab15].

Molecular Function: GTPase Activity and the Nucleotide Cycle

RAB15, like all Rab family GTPases, functions as a molecular switch that alternates between two conformational states determined by the bound guanine nucleotide. In the GTP-bound active state, the protein undergoes conformational changes primarily localized to two flexible regions termed switch I and switch II, which form the binding interface for downstream effector proteins [hutagalung-2011-rab-review-abstract]. The intrinsic GTPase activity of RAB15 hydrolyzes GTP to GDP, returning the protein to its inactive conformation. This cycling between active and inactive states is essential for the temporal and spatial regulation of membrane trafficking events.

The GTPase cycle of Rab proteins is typically controlled by two classes of regulatory proteins: guanine nucleotide exchange factors (GEFs) that catalyze the exchange of GDP for GTP, thereby activating the Rab, and GTPase-activating proteins (GAPs) that accelerate the intrinsically slow rate of GTP hydrolysis, thereby inactivating the Rab. Notably, comprehensive surveys of Rab-GEF-GAP relationships have identified no specific GEF or GAP for RAB15 to date, suggesting that the canonical regulatory mechanisms controlling RAB15 activation and inactivation remain largely unknown [hutagalung-2011-rab-review-abstract].

However, an important regulatory mechanism was identified through the discovery that MSS4 (Mammalian Suppressor of Sec4, also known as RABIF) serves as a binding partner for RAB15 [strick-2002-mss4-rab15-abstract]. MSS4 preferentially binds to the inactive GDP-bound form of RAB15 and functions as a molecular stabilizer rather than a classical GEF. A critical lysine residue at position 48 (K48) in RAB15 is essential for MSS4 binding; the K48Q mutation abolishes this interaction and reverses RAB15's inhibitory effects on receptor-mediated endocytosis in HeLa cells while maintaining normal transferrin receptor levels [strick-2002-mss4-rab15-abstract]. This establishes MSS4 as a novel regulatory factor that modulates RAB15's inhibitory function in endocytic trafficking, likely by stabilizing the inactive GDP-bound pool.

The prenylation of RAB15 at its C-terminal cysteine residues allows for membrane association, while GDP dissociation inhibitors (GDIs) can extract the inactive GDP-bound form from membranes and maintain a soluble cytosolic pool available for subsequent membrane targeting. The specificity of RAB15 membrane targeting likely involves membrane-localized GDI displacement factors, though the specific factors mediating RAB15 delivery to its target compartments have not been characterized.

Subcellular Localization and Endosomal Compartmentalization

RAB15 exhibits a distinctive dual localization pattern within the endosomal system, associating with both early/sorting endosomes and the perinuclear endocytic recycling compartment (ERC). Biochemical fractionation and confocal immunofluorescence microscopy studies demonstrated that RAB15 colocalizes extensively with Rab4 and Rab5 on early/sorting endosomes, where it associates with the transferrin receptor, a classical marker of the endocytic pathway [zuk-1999-rab15-early-endocytic-abstract]. Simultaneously, RAB15 colocalizes with Rab11 on the pericentriolar recycling endosomes, suggesting that this GTPase may function to link these distinct endosomal compartments [strick-2005-rep15-effector-abstract].

The subcellular distribution of RAB15 was confirmed through data from the Human Protein Atlas, which reports that the protein localizes to vesicles and centriolar satellites with a predicted intracellular localization [hpa-rab15-expression-summary]. NCBI Gene Ontology annotations indicate that RAB15 localizes to cilia, endosome membranes, and the perinuclear region of the cytoplasm, as well as to the plasma membrane and extracellular exosomes [ncbi-gene-rab15]. This vesicular localization pattern is consistent with roles in both endocytic and exocytic membrane trafficking processes. Importantly, RAB15 does not associate with late endosomal or lysosomal markers, indicating that its function is confined to the early and recycling segments of the endocytic pathway rather than the degradative branch [zuk-1999-rab15-early-endocytic-abstract].

Beyond the endosomal system, a comprehensive Rab screening identified RAB15 on the limiting membrane of Weibel-Palade bodies (WPBs), specialized secretory organelles in endothelial cells [zografou-2012-wpb-exocytosis-abstract]. This unexpected localization expands the known subcellular distribution of RAB15 and reveals a previously unappreciated role in exocytic pathways.

The presence of RAB15 on multiple compartments suggests it may coordinate trafficking between these organelles, potentially through the recruitment of distinct effector proteins at each location. This hypothesis is supported by the compartment-specific localization of REP15, a Rab15 effector that associates with RAB15 specifically at the ERC but not at sorting endosomes [strick-2005-rep15-effector-abstract].

Role in Endocytic Trafficking: An Inhibitory GTPase

The functional analysis of RAB15 in membrane trafficking has revealed an unexpected role as an inhibitory regulator of early endocytic events. Overexpression of wild-type RAB15 or a constitutively active GTP-bound mutant (Q67L) in Chinese hamster ovary (CHO) cells significantly reduced both receptor-mediated and fluid-phase endocytosis, while not affecting the rate of recycling from early endosomal compartments [zuk-1999-rab15-early-endocytic-abstract; zuk-2000-rab15-differential-abstract]. The inhibition of early endocytosis by active RAB15 appears to result from a reduction in the rate of homotypic early endosome fusion, a process that is essential for cargo progression through the early endocytic pathway.

Conversely, overexpression of constitutively inactive RAB15 mutants, particularly those defective in guanine nucleotide binding (N121I), stimulated both early endocytosis and endosome fusion [zuk-2000-rab15-differential-abstract]. These dominant-negative mutants also uniquely impacted recycling pathways and differentially regulated the transit of various endocytic tracers through sorting endosomes. The opposing effects of active versus inactive RAB15 mutants strongly support a model in which RAB15 functions as a negative regulator of early endocytic trafficking.

The relationship between RAB15 and RAB5, the master regulator of early endocytosis, is particularly instructive. Experimental data suggest that RAB15 counteracts the well-established stimulatory effects of RAB5 on early endocytosis. Overexpression of constitutively active RAB15 (Q67L) attenuated RAB5-stimulated endocytosis, whereas the constitutively inactive RAB15 mutant (N121I) augmented RAB5-stimulated endocytosis [zuk-2000-rab15-differential-abstract]. This functional antagonism suggests that RAB15 and RAB5 may form a regulatory circuit that fine-tunes the rate of cargo entry and progression through the early endocytic pathway. The mechanism by which RAB15 opposes RAB5 function does not appear to involve direct interference with RAB5 effectors, but rather operates through independent mechanisms potentially involving the MSS4-mediated stabilization of inactive RAB15 [strick-2002-mss4-rab15-abstract].

Role in Exocytosis: Weibel-Palade Body Secretion

A landmark study by Zografou and colleagues revealed an unexpected role for RAB15 in regulated exocytosis [zografou-2012-wpb-exocytosis-abstract]. Through comprehensive screening of all Rab GTPases for association with Weibel-Palade bodies (WPBs)—endothelial cell-specific secretory organelles that store and release von Willebrand factor and other hemostatic and inflammatory mediators—the researchers identified RAB15, along with Rab33 and Rab37, as novel WPB-associated Rabs, in addition to the previously known Rab27a and Rab3d.

Functional analysis using siRNA knockdown demonstrated that among these five WPB-localized Rabs, only Rab3, Rab27, and RAB15 are required for exocytosis. Strikingly, RAB15 was found to cooperate with RAB27A in WPB secretion, with both GTPases acting through a shared effector protein, MUNC13-4 [zografou-2012-wpb-exocytosis-abstract]. MUNC13-4 is a member of the Munc13 family of proteins that are essential for membrane fusion in regulated secretion. It functions as a priming factor that promotes SNARE complex formation and is required for the exocytosis of secretory lysosomes in various cell types.

The discovery that MUNC13-4 serves as an effector for both RAB27A and RAB15 suggests that these two Rabs function coordinately rather than redundantly in WPB exocytosis. The role of an "endocytic Rab" (RAB15) in exocytosis may relate to the well-characterized delivery of WPB components from endosomes. For example, CD63, an essential cofactor of the WPB integral membrane protein P-selectin, is delivered to WPBs via the endosomal system. RAB15 may therefore coordinate the endosomal contribution to WPB biogenesis and maturation with the regulated secretion of these organelles [zografou-2012-wpb-exocytosis-abstract].

This dual role of RAB15 in both endocytosis and exocytosis places it in a unique position to coordinate bidirectional membrane trafficking pathways, potentially linking the delivery of cargo to secretory organelles with their subsequent release at the plasma membrane.

REP15: A Compartment-Specific Effector Protein

The identification of RAB15 effector protein (REP15) provided crucial mechanistic insight into how RAB15 executes its function at the endocytic recycling compartment. REP15 was discovered through yeast two-hybrid screening as a novel binding partner that interacts specifically with GTP-bound RAB15 but not with RAB5 or RAB11 [strick-2005-rep15-effector-abstract]. This nucleotide-dependent interaction is characteristic of bona fide Rab effectors, which recognize structural features exposed only in the active GTP-bound state.

REP15 exhibits compartment-specific localization within the endosomal system: it colocalizes with RAB15 and RAB11 on the perinuclear endocytic recycling compartment but does not associate with sorting endosome markers such as Rab4 or EEA1 (early endosome antigen 1) [strick-2005-rep15-effector-abstract]. This restricted localization distinguishes REP15 from RAB15 itself, which is present on both sorting endosomes and the ERC, and suggests that RAB15 recruits different effector proteins depending on its subcellular location.

Functional studies demonstrated that REP15 is required specifically for receptor recycling from the ERC back to the plasma membrane. Both REP15 overexpression and siRNA-mediated depletion inhibited transferrin receptor recycling from the ERC by approximately 47-51%, without affecting receptor entry into the early endocytic pathway or fast recycling from sorting endosomes [strick-2005-rep15-effector-abstract]. These findings establish that the rapid and slow modes of transferrin receptor recycling are mechanistically distinct pathways, and that REP15-mediated slow recycling from the ERC represents a specific RAB15-dependent pathway.

More recent structural and biochemical characterization has revealed that REP15 possesses an unusual globular fold composed of 7 α-helices and 7 β-strands, distinct from the primarily α-helical coiled-coil domains employed by most characterized Rab effectors [rai-2022-rep15-structure-abstract]. The REP15:RAB15 interaction occurs with moderate affinity (KD = 0.47 ± 0.12 µM) and involves both enthalpic and entropic contributions. Importantly, REP15 also interacts with Rab3 paralogs (KD = 0.48-2.16 µM) and Rab34 (KD = 64 ± 32 nM), indicating that this effector serves multiple Rab GTPases [rai-2022-rep15-structure-abstract]. The selectivity for RAB15 and Rab3 paralogs is conferred by a critical tyrosine residue in the RabSF3 motif (RYRTIT), as mutation of this tyrosine to phenylalanine dramatically reduces REP15 binding affinity.

MICAL Proteins: Linking RAB15 to Cytoskeletal Regulation

Beyond REP15 and MUNC13-4, RAB15 interacts with MICAL (Molecule Interacting with CasL) family proteins, revealing an unexpected connection between endocytic trafficking and cytoskeletal dynamics. MICAL proteins are multidomain flavoprotein monooxygenases that catalyze the oxidation of specific methionine residues (Met44 and Met47) in actin filaments, leading to robust F-actin disassembly [mical-rab-interaction-summary]. The MICAL family includes three members (MICAL1, MICAL2, MICAL3) that share a common domain architecture consisting of an N-terminal monooxygenase domain, a calponin homology domain, a LIM domain, and a C-terminal bMERB domain that mediates Rab binding.

RAB15 is among a subset of phylogenetically related endosomal Rabs (including Rab1, Rab8, Rab10, Rab13, and Rab35) that interact with MICAL family proteins through their bMERB domain [mical-rab-interaction-summary]. Isothermal titration calorimetry measurements revealed that RAB15 binds to the MICAL bMERB domain in a 1:2 stoichiometry, with a high-affinity site (KD = 2.5 nM) and a lower-affinity site (KD = 2.91 µM). The binding of active GTP-bound Rab proteins, including RAB15, relieves an intramolecular autoinhibition in MICAL proteins, thereby activating their monooxygenase activity and enabling actin oxidation [mical-rab-interaction-summary].

This interaction suggests that RAB15 may coordinate membrane trafficking events with localized cytoskeletal remodeling, a coupling that would be particularly relevant in polarized cells such as neurons, where directional vesicle transport and actin dynamics must be tightly integrated.

Tissue Expression and Brain Enrichment

RAB15 exhibits a distinctive tissue expression pattern characterized by enrichment in the central nervous system. Expression profiling data from the Human Protein Atlas demonstrate that RAB15 mRNA is expressed broadly across human tissues but shows highest levels in the cerebellum (77.9 nTPM) and cerebral cortex (67.1 nTPM), with the posterior cingulate cortex exhibiting particularly elevated expression [hpa-rab15-expression-summary]. Outside the nervous system, notable expression is observed in the parathyroid gland (37.0 nTPM) and heart muscle (31.5 nTPM). NCBI data indicate highest RPKM values in brain (21.8) and urinary bladder (12.3), with expression documented across more than 21 tissues [ncbi-gene-rab15].

At the single-cell level, RAB15 expression is enhanced in several specialized epithelial cell types, including salivary duct cells (140.0 nCPM, the highest observed level), conjunctival goblet cells (57.3 nCPM), and prostatic club cells (45.5 nCPM). Within the brain, excitatory neurons show substantial RAB15 expression (48.7 nCPM) [hpa-rab15-expression-summary]. The widespread cytoplasmic expression across tissues, combined with brain enrichment, suggests that RAB15 serves a general housekeeping function in endocytic trafficking while also fulfilling specialized roles in neurons and other secretory cell types.

The brain-enriched expression pattern of RAB15 led to its designation as a brain-specific Rab in early studies, though subsequent work has clarified that expression is tissue-enhanced rather than absolutely restricted [zuk-1999-rab15-early-endocytic-abstract; nishimura-2011-rab15-retinoic-acid-abstract]. RAB15 has been identified as a downstream target of Atoh1, a basic helix-loop-helix transcription factor that specifies neuronal identity in the developing cerebellum, inner ear hair cells, and Merkel cells [nishimura-2011-rab15-retinoic-acid-abstract]. The expression of RAB15 in endothelial cells, where it participates in Weibel-Palade body exocytosis, further demonstrates that its functional repertoire extends beyond the nervous system [zografou-2012-wpb-exocytosis-abstract].

Alternative Splicing and Neuroblastoma

RAB15 gene expression is subject to alternative splicing, generating multiple protein isoforms with potentially distinct functions. According to NCBI Gene data, three primary transcript variants and protein isoforms exist: isoform 1 (from the longest transcript NM_198686.3), isoform 2 (NM_001308154.2, with an alternate splice producing a novel C-terminus), and isoform 3 (NM_001330182.2, using a downstream start codon producing a shortened N-terminus) [ncbi-gene-rab15].

Two major isoforms were initially characterized in neuroblastoma research: Rab15CN (composed of 7 exons encoding 212 amino acids with brain-specific expression) and Rab15AN, which shows different tissue distribution [nishimura-2011-rab15-retinoic-acid-abstract]. Subsequent studies identified additional alternatively spliced variants designated Rab15AN2 and Rab15AN3, both of which contain premature termination codons; however, these transcripts are detected in both tumor cells and normal human tissues, with differential expression in brain and testis [pham-2012-rab15-splicing-abstract].

The relationship between RAB15 expression and neuroblastoma, an aggressive pediatric tumor accounting for approximately 15% of cancer-related deaths in children, has been the subject of several investigations. Retinoic acid treatment of neuroblastoma cell lines induces neuronal differentiation, and this process is accompanied by specific upregulation of the Rab15CN isoform [nishimura-2011-rab15-retinoic-acid-abstract]. Cells expressing predominantly Rab15AN showed reduced responsiveness to retinoic acid-induced differentiation, suggesting that the balance between RAB15 isoforms may predict therapeutic response to differentiation-inducing agents.

Further investigation revealed that tumor-initiating cells (TICs) isolated from neuroblastoma cell lines as spheres exhibit altered RAB15 splicing compared to parental adherent cells. The ratio of Rab15CN to total alternatively spliced isoforms (Rab15AN1+AN2+AN3) was significantly decreased in spheres, suggesting that this splicing pattern might serve as a biomarker to distinguish tumor-initiating cells from bulk tumor populations [pham-2012-rab15-splicing-abstract]. Whether these splicing changes directly contribute to tumorigenic phenotypes or represent secondary consequences of dedifferentiation remains to be determined.

Disease Associations and Cancer

Beyond neuroblastoma, RAB15 has emerged as a potential biomarker in other cancers. According to Human Protein Atlas data, RAB15 serves as a prognostic marker in liver hepatocellular carcinoma, with varying expression levels across different cancer types [hpa-rab15-expression-summary]. In colorectal cancer, RAB15 is among seven RAB GTPases (including RAB10, RAB11A, RAB17, RAB19, RAB20, and RAB25) that show significant upregulation in tumor tissues compared to normal tissues. These upregulated RABs are associated with the metabolic CMS3 subtype of colorectal cancer, which displays remarkable metabolic deregulation and a high frequency of KRAS mutations. Recent multi-omics analysis has also suggested REP15 as a novel colorectal cancer-specific driving gene [rai-2022-rep15-structure-abstract].

Unlike RAS oncoproteins, no activating mutations in RAB15 or other Rab GTPases have been identified in human cancers to date. According to OMIM, no disease phenotypes are currently directly attributed to RAB15 mutations [omim-619547]. Instead, the disease relevance of Rab proteins appears to derive primarily from altered expression levels, suggesting that quantitative changes in membrane trafficking capacity contribute to cancer cell phenotypes. The functional consequences of REP15 depletion—including reduced cell proliferation, impaired migration, and decreased anchorage-independent growth in glioblastoma cells [rai-2022-rep15-structure-abstract]—support a model in which RAB15-dependent trafficking pathways influence cellular behaviors relevant to tumor progression.

Open Questions

Several fundamental aspects of RAB15 biology remain poorly understood and represent important areas for future investigation:

1. GEF and GAP identification: While MSS4/RABIF has been identified as a stabilizer for GDP-bound RAB15, no classical GEF or GAP has been identified for RAB15. Identifying these regulators would be essential for understanding how RAB15 activity is spatially and temporally controlled within cells.

2. Structural basis of RAB15 function: While crystal structures exist for the Rep15:Rab3 complexes, no structure of RAB15 itself or the Rep15:RAB15 complex has been determined. Such structures would reveal the conformational details of RAB15 switch regions and effector binding interfaces.

3. Neuronal functions: The brain-enriched expression of RAB15 suggests specialized neuronal functions, but the specific roles of RAB15 in synaptic transmission, receptor trafficking, or neuronal polarity have not been systematically investigated.

4. Coordination of endocytosis and exocytosis: The dual role of RAB15 in both endocytic recycling and Weibel-Palade body exocytosis raises questions about how these functions are coordinated and whether similar dual roles exist in other cell types.

5. Relationship to RAB5/RAB11/RAB27 pathways: The functional antagonism between RAB15 and RAB5, the cooperation with RAB27A in exocytosis, and colocalization with RAB11 at the ERC suggest complex regulatory interplay that remains to be fully elucidated.

6. Alternative splicing regulation: The mechanisms controlling RAB15 alternative splicing and the functional consequences of different isoforms require further characterization, particularly in the context of neuronal differentiation and cancer.

7. In vivo functions: No RAB15 knockout mouse model has been extensively characterized, leaving the physiological requirements for RAB15 in development and adult tissue homeostasis uncertain.

References

• [zuk-1999-rab15-early-endocytic-abstract]: Zuk PA, Elferink LA. Rab15 mediates an early endocytic event in Chinese hamster ovary cells. J Biol Chem. 1999;274(32):22303-22312. PMID: 10428799. DOI: 10.1074/jbc.274.32.22303. https://pubmed.ncbi.nlm.nih.gov/10428799/

• [zuk-2000-rab15-differential-abstract]: Zuk PA, Elferink LA. Rab15 differentially regulates early endocytic trafficking. J Biol Chem. 2000;275(35):26754-26764. PMID: 10837464. DOI: 10.1074/jbc.M000344200. https://pubmed.ncbi.nlm.nih.gov/10837464/

• [strick-2002-mss4-rab15-abstract]: Strick DJ, Francescutti DM, Zhao Y, Elferink LA. Mammalian suppressor of Sec4 modulates the inhibitory effect of Rab15 during early endocytosis. J Biol Chem. 2002;277(36):32722-32729. PMID: 12105226. DOI: 10.1074/jbc.M205101200. https://pubmed.ncbi.nlm.nih.gov/12105226/

• [strick-2005-rep15-effector-abstract]: Strick DJ, Elferink LA. Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment. Mol Biol Cell. 2005;16(12):5699-5709. PMID: 16195351. PMCID: PMC1289414. DOI: 10.1091/mbc.E05-03-0204. https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/

• [zografou-2012-wpb-exocytosis-abstract]: Zografou S, Basagiannis D, Papafotika A, Shirakawa R, Horiuchi H, Auerbach D, Fukuda M, Christoforidis S. A complete Rab screening reveals novel insights in Weibel-Palade body exocytosis. J Cell Sci. 2012;125(Pt 20):4780-4790. PMID: 22899725. DOI: 10.1242/jcs.104174. https://pubmed.ncbi.nlm.nih.gov/22899725/

• [rai-2022-rep15-structure-abstract]: Rai A, Singh AK, Bleimling N, Posern G, Vetter IR, Goody RS. Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. Nat Commun. 2022;13:4262. PMID: 35871249. PMCID: PMC9308819. DOI: 10.1038/s41467-022-31831-1. https://pmc.ncbi.nlm.nih.gov/articles/PMC9308819/

• [nishimura-2011-rab15-retinoic-acid-abstract]: Nishimura N, et al. Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells. Oncol Rep. 2011;26(1):145-151. PMID: 21491086. DOI: 10.3892/or.2011.1255. https://pubmed.ncbi.nlm.nih.gov/21491086/

• [pham-2012-rab15-splicing-abstract]: Pham TV, et al. Rab15 alternative splicing is altered in spheres of neuroblastoma cells. Oncol Rep. 2012;27(6):2045-2049. PMID: 22427180. DOI: 10.3892/or.2012.1731. https://pubmed.ncbi.nlm.nih.gov/22427180/

• [hutagalung-2011-rab-review-abstract]: Hutagalung AH, Novick PJ. Role of Rab GTPases in Membrane Traffic and Cell Physiology. Physiol Rev. 2011;91(1):119-149. PMID: 21248164. PMCID: PMC3710122. DOI: 10.1152/physrev.00059.2009. https://pmc.ncbi.nlm.nih.gov/articles/PMC3710122/

• [hpa-rab15-expression-summary]: Human Protein Atlas. RAB15 protein expression summary. https://www.proteinatlas.org/ENSG00000139998-RAB15

• [ncbi-gene-rab15]: NCBI Gene. RAB15 RAB15, member RAS oncogene family [Homo sapiens (human)]. Gene ID: 376267. https://www.ncbi.nlm.nih.gov/gene/376267

• [omim-619547]: OMIM. RAB15, MEMBER RAS ONCOGENE FAMILY; RAB15. Entry 619547. https://omim.org/entry/619547

• [mical-rab-interaction-summary]: Multiple sources on MICAL-Rab interactions including PMC3993057 and recent structural studies on MICAL autoinhibition and Rab binding.

Citations

1. hpa-rab15-expression-summary.md
2. hutagalung-2011-rab-review-abstract.md
3. mical-rab-interaction-summary.md
4. nishimura-2011-rab15-retinoic-acid-abstract.md
5. pham-2012-rab15-splicing-abstract.md
6. rai-2022-rep15-structure-abstract.md
7. strick-2002-mss4-rab15-abstract.md
8. strick-2005-rep15-effector-abstract.md
9. zografou-2012-wpb-exocytosis-abstract.md
10. zuk-1999-rab15-early-endocytic-abstract.md
11. zuk-2000-rab15-differential-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: Human RAB15 (UniProt P59190)

Plan (concise)
- Verify identity and family: human RAB15, small GTPase, Rab family, P‑loop NTPase. (Verified; see below.)
- Synthesize mechanistic function, localization, interactors, and pathway context from authoritative primary and review literature.
- Prioritize recent developments (2023–2024) for disease associations/applications; integrate earlier mechanistic work for precision.
- Provide quantitative data where available; include URLs and publication dates.

1) Key concepts and definitions
- Identity and family: RAB15 is a human small GTPase of the Rab family that regulates membrane trafficking steps in endocytosis and recycling. Like other Rabs, it cycles between GDP- and GTP-bound states via conserved switch I/II regions and is membrane-anchored by C‑terminal geranylgeranyl prenylation. This matches the UniProt description (small GTPase, P‑loop NTPase; Rab family) and organism (Homo sapiens) (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 3-4).
- Subcellular localization: RAB15 localizes to sorting/early endosomes (SEs/EEs) and the perinuclear endocytic recycling compartment (ERC), where it co-resides with Rab4/5 on SEs and Rab11 on ERC. In polarized contexts, RAB15 has also been associated with apical recycling routes (ARE) (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 4-5, bhuin2014rabproteinsthe pages 3-4). Reviews of endocytic Rab compartmentalization place RAB15 in EE/RE domains (Nov 2011, Clinical Genetics; https://doi.org/10.1111/j.1399-0004.2011.01724.x) (agola2011rabgtpasesas pages 2-3).
- Primary cargo/process: RAB15 regulates endocytic sorting and recycling of the transferrin receptor (TfR), helping partition cargo between rapid recycling from SEs and slower recycling via the ERC (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8).

2) Recent developments and latest research (prioritize 2023–2024)
- Cancer multi-omics signatures: In a 2024 colon cancer study constructing an LLPS-related risk score (LRRS) across TCGA/GEO cohorts, RAB15 was among model genes upregulated in tumors and contributing to a prognostic signature associated with immune features and poor outcomes. While mechanistic roles were not dissected for RAB15, its inclusion highlights contemporary disease relevance (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613) (wang2024anovelliquidliquid pages 13-16).
- Hypopharyngeal cancer theranostics: A 2022 functional-theranostic study tested candidate biomarkers for docetaxel/cisplatin/5-FU response. RAB15 overexpression increased drug resistance in one transfectant clone but not another, indicating inconsistent functional linkage; nonetheless, RAB15 was evaluated as a potential exploratory biomarker (Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (kawatashimamura2022biomarkerdiscoveryfor pages 7-10).
- Neuronal trafficking frameworks: Contemporary reviews continue to place Rab proteins (including RAB15) in neuronal endosomal sorting and polarity, with inhibitory effects on endocytosis and potential negative regulation of recycling discussed in the context of RUFY/RUN-domain effectors (2013 review; Mar 2013, Int J Mol Sci; https://doi.org/10.3390/ijms14036487) (kitagishi2013rufyraband pages 7-9).

3) Mechanism, cellular role, localization, and pathway context
- Biochemical activity and cycle: RAB15 conforms to Rab GTPase biochemistry—GDP/GTP cycling through GEFs and GAPs, membrane association via C‑terminal dual geranylgeranyl groups, and effector binding in the GTP state. The general Rab paradigm and RAB15’s placement within it are well established (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 3-4). Mss4 has been reported to modulate RAB15’s inhibitory effect on TfR trafficking in earlier work referenced alongside REP15 discovery (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 2-3).
- Subcellular localization and domains in the endocytic system: Imaging and biochemical fractionation show RAB15 on SEs and ERC. Its effector REP15 predominantly localizes to the Rab11-positive ERC, not SEs (co-IP with Rab11 and TfR; no association with EEA1), consistent with a role in ERC-mediated recycling (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6).
- Effector specificity—REP15: REP15 was identified as a direct, specific RAB15 effector that prefers RAB15-GTP, colocalizes perinuclearly with RAB15, and regulates TfR recycling. Two-hybrid assays detected strong interaction with RAB15 WT/Q67L but not T22N/N121I; REP15 did not bind Rab11 mutants in similar assays, despite ERC colocalization (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 2-3, strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8).
- Functional impact on cargo flow: Overexpression of REP15 causes accumulation of internalized TfR and decreased surface TfR without altering TfR internalization kinetics, indicating a selective defect in ERC-to-plasma membrane recycling. Fast recycling from SEs remains intact, consistent with REP15 acting at the ERC branch controlled by RAB15 (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- Role within Rab5/Rab4/Rab11 axes: RAB15 is assigned roles in both fast (with Rab4) and slow (with Rab11) recycling circuits emanating from the EE/SE decision point, and may counteract Rab5-driven stimulation of endocytosis. This positions RAB15 as a modulator of sorting at the EE and output via ERC (Nov 2011, Clinical Genetics; https://doi.org/10.1111/j.1399-0004.2011.01724.x; Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (agola2011rabgtpasesas pages 2-3, bhuin2014rabproteinsthe pages 4-5).
- Related recycling machinery and complexes: Endocytic recycling involves EHD/MICAL-L1–decorated tubular membranes and multiple Rab effectors. While MICAL-L1/EHD1 regulate transferrin and integrin recycling and share interaction paradigms with Rab effectors, REP15 is the RAB15-specific effector documented to control ERC-mediated recycling. Reports also note RAB15 involvement in apical recycling in polarized epithelial systems (Aug 2010, World J Biol Chem; https://doi.org/10.4331/wjbc.v1.i8.254; Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (rahajeng2010importantrelationshipsbetween pages 4-6, bhuin2014rabproteinsthe pages 3-4).

4) Expert opinions and analysis from authoritative sources
- Endosomal domain model: Rab GTPases create mosaic domains that sort cargo and confer directionality via effector networks. Authoritative reviews place RAB15 among EEs/REs, emphasizing its role at the sorting/recycling interface and listing it in both fast and slow recycling circuits—a relatively uncommon dual placement that underscores context-specific engagement (Nov 2011, Clinical Genetics; https://doi.org/10.1111/j.1399-0004.2011.01724.x) (agola2011rabgtpasesas pages 2-3).
- Inhibitory role in endocytosis: Reviews summarize that RAB15 overexpression inhibits fluid-phase and receptor-mediated endocytosis and in vitro inhibits homotypic EE fusion, suggesting an antagonistic relationship with Rab5-driven entry, while selectively affecting recycling from early compartments depending on mutant state (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 4-5).

5) Relevant statistics and data from recent/primary studies
- Co-localization metrics (confocal microscopy): REP15 colocalizes with RAB15 WT 63 ± 3.4% and with RAB15-Q67L 70 ± 4.4% (perinuclear enrichment). REP15 overlaps with endogenous Rab11 56 ± 7.1% in the ERC; no significant overlap with EEA1 or Rab4 (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6).
- Transferrin traffic dynamics: Following a 1-min chase, Alexa‑Tf colocalizes 57.9 ± 13.6% with EEA1 (SEs), 11.1 ± 3.0% with Rab11, and 23.8 ± 3.8% with REP15; after a 30‑min chase, Rab11 68.1 ± 4.3% and REP15 54.4 ± 1.8%, consistent with ERC arrival (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- Internalization kinetics (biotinylation assays): TfR internalization rate constants Ke were similar with or without REP15 overexpression (0.2630 ± 0.035 min⁻¹ vs 0.2435 ± 0.052 min⁻¹), indicating REP15’s effect is on recycling rather than internalization (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- Fast vs slow recycling specificity: REP15 overexpression reduced ERC-derived recycling but left rapid SE-mediated recycling unchanged, reinforcing RAB15–REP15 specificity for the ERC branch (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- 2024 cancer signature (LRRS): The Frontiers in Immunology study reports an LLPS-related 14‑gene signature that includes RAB15, upregulated in tumors and associated with immune and prognostic differences across colon cancer cohorts (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613) (wang2024anovelliquidliquid pages 13-16).
- 2022 hypopharyngeal cancer theranostics: RAB15 overexpression increased docetaxel and cisplatin resistance in one clone but not another in BICR6 cells; no consistent correlation was validated across all transfectants, cautioning interpretation (Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (kawatashimamura2022biomarkerdiscoveryfor pages 7-10).

6) Current applications and real-world implementations
- Biomarker exploration: RAB15 has been evaluated as a component of prognostic/molecular signatures (e.g., LLPS-related risk scores in colon cancer) and as an exploratory biomarker in drug-response prediction for hypopharyngeal cancer. These applications are early-stage and largely computational/experimental; clinical utility remains to be validated (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613; Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (wang2024anovelliquidliquid pages 13-16, kawatashimamura2022biomarkerdiscoveryfor pages 7-10).
- Mechanistic experimental systems: RAB15–REP15 tools (mutants, overexpression/siRNA) are used to dissect EE/SE versus ERC recycling of TfR in human cell lines, providing a reference system for endocytic pathway perturbation (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8).

7) Disease/physiology links and expert analysis
- Neuronal biology: Endosomal recycling and Rab networks are central to neuronal polarity and synaptic function. RAB15 is discussed as inhibitory for endocytosis and potentially a negative regulator of recycling in neuronal contexts, although direct RAB15-focused neuronal in vivo data remain limited relative to other Rabs (Mar 2013, Int J Mol Sci; https://doi.org/10.3390/ijms14036487) (kitagishi2013rufyraband pages 7-9).
- Epithelial polarity and apical recycling: Reviews enumerate RAB15 among Rabs implicated in apical recycling/transcytosis, consistent with its ERC/ARE distribution and role in routing cargo to the plasma membrane (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 3-4, bhuin2014rabproteinsthe pages 4-5).
- Oncology: Contemporary signatures implicate RAB15 expression changes in tumor biology; mechanistic oncogenic roles for RAB15 per se are not established, and functional data are mixed in cell-based drug response assays, suggesting any biomarker role should be validated in disease-relevant systems (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613; Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (wang2024anovelliquidliquid pages 13-16, kawatashimamura2022biomarkerdiscoveryfor pages 7-10).

Key artifact (concise fact table)
| Aspect | Evidence-based summary (with context IDs) | Quantitative data (numeric values where available, with context IDs) | Representative sources |
|---|---|---:|---|
| Identity / Family | Small GTPase, Rab family; human RAB15 (UniProt P59190) implicated in endocytic trafficking and recycling (bhuin2014rabproteinsthe pages 3-4, agola2011rabgtpasesas pages 2-3). | — | Bhuin & Roy 2014; Agola et al. 2011 |
| Biochemical activity (GTPase cycle; interaction with Mss4) | Functions as a canonical Rab: cycles GDP/GTP, membrane-associated via prenylation; Mss4 reported to modulate Rab15's inhibitory effect on TfR trafficking (bhuin2014rabproteinsthe pages 3-4, strick2005rab15effectorprotein pages 2-3). | — | Bhuin & Roy 2014; Strick & Elferink 2005 |
| Subcellular localization | Localizes to sorting/early endosomes (SEs) and perinuclear endocytic recycling compartment (ERC); also reported in apical/ARE contexts in polarized cells (bhuin2014rabproteinsthe pages 4-5, agola2011rabgtpasesas pages 2-3, bhuin2014rabproteinsthe pages 3-4). | — | Agola et al. 2011; Bhuin & Roy 2014; Rahajeng et al. 2010 |
| Effectors (REP15 specificity and Rab15-GTP binding) | REP15 identified as a Rab15-specific effector that preferentially binds GTP-bound Rab15 and colocalizes on ERC membranes; REP15 does not bind Rab5 or Rab11 in two-hybrid/binding assays (strick2005rab15effectorprotein pages 1-2, strick2005rab15effectorprotein pages 2-3, strick2005rab15effectorprotein pages 4-6). | Binding specificity: REP15 binds Rab15-GTP (strong) and shows little/no binding to Rab5 or Rab11 in assays (strick2005rab15effectorprotein pages 2-3, strick2005rab15effectorprotein pages 4-6). | Strick & Elferink 2005 |
| Cargo regulated (example) | Transferrin receptor (TfR) trafficking is a well-characterized cargo: Rab15 and its effector REP15 regulate sorting between SEs and ERC and recycling to plasma membrane (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8). | Altered TfR accumulation in REP15-overexpressing cells (see kinetics below) (strick2005rab15effectorprotein pages 4-6). | Strick & Elferink 2005 |
| Functional role in recycling | Rab15 modulates endocytic sorting and both fast and slow recycling routes; overexpression/inactive mutants differentially alter TfR trafficking—Rab15 can inhibit endocytic internalization and affect ERC-derived (slower) recycling (bhuin2014rabproteinsthe pages 4-5, agola2011rabgtpasesas pages 2-3, strick2005rab15effectorprotein pages 4-6). | REP15 overexpression → accumulation of internalized TfR (peak later than control), indicating inhibited ERC→plasma membrane recycling (strick2005rab15effectorprotein pages 4-6). | Bhuin & Roy 2014; Agola et al. 2011; Strick & Elferink 2005 |
| Interplay with Rab5 / Rab4 / Rab11 axes | Rab15 occupies SE/RE domains alongside Rab5, Rab4 and Rab11 and is described as part of both fast (Rab4/Rab15) and slow (Rab11/Rab15) recycling circuits; may counteract Rab5-driven stimulation of endocytosis (bhuin2014rabproteinsthe pages 4-5, agola2011rabgtpasesas pages 2-3). | — | Agola et al. 2011; Bhuin & Roy 2014 |
| Representative co-localization metrics | REP15 colocalization with Rab15 and Rab11 and Alexa-Tfn dynamics through SE→ERC are quantified in cell imaging experiments (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8). | REP15 colocalized with WT Rab15: 63 ± 3.4% and with Rab15-Q67L: 70 ± 4.4%; cMyc-REP15 with Rab15 (perinuclear): 54 ± 5.2% and 56 ± 4.4%; cMyc-REP15 overlap with Rab11: 56 ± 7.1% (strick2005rab15effectorprotein pages 4-6). Alexa-Tfn colocalization: at 1-min chase EEA1 57.9 ± 13.6%; Rab11 11.1 ± 3.0%; REP15 23.8 ± 3.8%; at 30-min chase Rab11 68.1 ± 4.3% and REP15 54.4 ± 1.8% (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8). | Strick & Elferink 2005 |
| Internalization vs recycling kinetics | Surface biotinylation/internalization assays measured internalization and recycling rate constants; REP15 overexpression changes recycling dynamics consistent with ERC retention (strick2005rab15effectorprotein pages 4-6). | Internalization rate constants (Ke): REP15-overexpressing cells Ke = 0.2630 ± 0.035 min⁻¹ vs control Ke = 0.2435 ± 0.052 min⁻¹ (strick2005rab15effectorprotein pages 4-6). | Strick & Elferink 2005 |
| Disease / physiology associations (2022–2024) | Reports link RAB15 expression to cancer signatures and biomarker studies with inconsistent functional effects on drug sensitivity; roles proposed in neuronal polarity/trafficking and reproductive proteomics signatures (kawatashimamura2022biomarkerdiscoveryfor pages 7-10, wang2024anovelliquidliquid pages 13-16, rahajeng2010importantrelationshipsbetween pages 4-6). | Kawata-Shimamura et al. 2022: RAB15 overexpression increased resistance in some transfectants but results were inconsistent across variants; Wang et al. 2024: RAB15 upregulated in an LLPS-related colon cancer signature (kawatashimamura2022biomarkerdiscoveryfor pages 7-10, wang2024anovelliquidliquid pages 13-16). | Kawata-Shimamura et al. 2022; Wang et al. 2024; Rahajeng et al. 2010 |

Table: Concise, evidence-linked summary of human RAB15 (UniProt P59190) covering identity, activity, localization, effectors, cargo, kinetics, and recent disease/physiology links; includes quantitative values and context-ID citations for traceability.

Verification of target identity and domains
- The literature positions RAB15 as a human Rab-family small GTPase involved in endosomal sorting/recycling, consistent with UniProt P59190 (Rab family, P‑loop NTPase). No conflicting gene symbol usage was found in the cited human-focused literature, and organism context is Homo sapiens (Oct 2014, Experimental Cell Research; Nov 2011, Clinical Genetics) (bhuin2014rabproteinsthe pages 3-4, agola2011rabgtpasesas pages 2-3).

Limitations and open questions
- Specific GEFs/GAPs for RAB15 beyond modulatory roles (e.g., Mss4) are not definitively established in the retrieved sources; RIN-family GEFs are well known for Rab5 but not specifically shown for RAB15 here (agola2011rabgtpasesas pages 2-3, strick2005rab15effectorprotein pages 2-3).
- Interactions with APPL1, EHD/MICAL-L1, and RUFY proteins are central to recycling in general, but direct physical links to RAB15 are not demonstrated in the sources beyond REP15; therefore, their involvement should be viewed as pathway-contextual rather than RAB15-specific (Aug 2010, World J Biol Chem; https://doi.org/10.4331/wjbc.v1.i8.254) (rahajeng2010importantrelationshipsbetween pages 4-6).

Conclusions
- RAB15 is a human endosomal Rab GTPase that coordinates sorting at EEs/SEs and regulates ERC-derived recycling to the plasma membrane. Its best-characterized effector, REP15, specifically binds RAB15-GTP and restricts TfR recycling from the ERC without altering entry or rapid SE recycling, placing the RAB15–REP15 module at the slow, ERC branch of the recycling pathway. Quantitative imaging and kinetic assays substantiate these roles. Recent systems-oncology studies implicate RAB15 expression in prognostic signatures; however, direct, disease-causal roles and clinical utility require further validation in relevant models (Dec 2005, Mol Biol Cell; Nov 2011, Clinical Genetics; Oct 2014, Experimental Cell Research; Dec 2024, Frontiers in Immunology; Jul 2022, BMC Cancer) (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8, agola2011rabgtpasesas pages 2-3, bhuin2014rabproteinsthe pages 3-4, wang2024anovelliquidliquid pages 13-16, kawatashimamura2022biomarkerdiscoveryfor pages 7-10).

References

1. (bhuin2014rabproteinsthe pages 3-4): Tanmay Bhuin and Jagat Kumar Roy. Rab proteins: the key regulators of intracellular vesicle transport. Experimental cell research, 328 1:1-19, Oct 2014. URL: https://doi.org/10.1016/j.yexcr.2014.07.027, doi:10.1016/j.yexcr.2014.07.027. This article has 339 citations and is from a peer-reviewed journal.

2. (bhuin2014rabproteinsthe pages 4-5): Tanmay Bhuin and Jagat Kumar Roy. Rab proteins: the key regulators of intracellular vesicle transport. Experimental cell research, 328 1:1-19, Oct 2014. URL: https://doi.org/10.1016/j.yexcr.2014.07.027, doi:10.1016/j.yexcr.2014.07.027. This article has 339 citations and is from a peer-reviewed journal.

3. (agola2011rabgtpasesas pages 2-3): J. Agola, Jim Pa, Heather H. Ward, Soumik Basuray, and A. Wandinger-Ness. Rab gtpases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clinical Genetics, 80:305-318, Oct 2011. URL: https://doi.org/10.1111/j.1399-0004.2011.01724.x, doi:10.1111/j.1399-0004.2011.01724.x. This article has 188 citations and is from a peer-reviewed journal.

4. (strick2005rab15effectorprotein pages 4-6): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

5. (strick2005rab15effectorprotein pages 6-8): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

6. (wang2024anovelliquidliquid pages 13-16): Shuo Wang, Sen Hou, Shan Jiang, Chao Wang, Peipei Zhang, Yingjiang Ye, and Zhidong Gao. A novel liquid-liquid phase separation-related gene signature for predicting prognosis in colon cancer. Frontiers in Immunology, Dec 2024. URL: https://doi.org/10.3389/fimmu.2024.1514613, doi:10.3389/fimmu.2024.1514613. This article has 0 citations and is from a peer-reviewed journal.

7. (kawatashimamura2022biomarkerdiscoveryfor pages 7-10): Yumiko Kawata-Shimamura, Hidetaka Eguchi, Reika Kawabata-Iwakawa, Mitsuhiko Nakahira, Yasushi Okazaki, Tetsuya Yoda, Reidar Grénman, Masashi Sugasawa, and Masahiko Nishiyama. Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents. BMC Cancer, Jul 2022. URL: https://doi.org/10.1186/s12885-022-09853-1, doi:10.1186/s12885-022-09853-1. This article has 6 citations and is from a peer-reviewed journal.

8. (kitagishi2013rufyraband pages 7-9): Yasuko Kitagishi and Satoru Matsuda. Rufy, rab and rap family proteins involved in a regulation of cell polarity and membrane trafficking. International Journal of Molecular Sciences, 14:6487-6498, Mar 2013. URL: https://doi.org/10.3390/ijms14036487, doi:10.3390/ijms14036487. This article has 44 citations and is from a poor quality or predatory journal.

9. (strick2005rab15effectorprotein pages 2-3): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

10. (rahajeng2010importantrelationshipsbetween pages 4-6): J. Rahajeng, S. Giridharan, Bishuang Cai, Naava Naslavsky, and S. Caplan. Important relationships between rab and mical proteins in endocytic trafficking. World journal of biological chemistry, 1 8:254-64, Aug 2010. URL: https://doi.org/10.4331/wjbc.v1.i8.254, doi:10.4331/wjbc.v1.i8.254. This article has 39 citations.

11. (strick2005rab15effectorprotein pages 1-2): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

Citations

1. bhuin2014rabproteinsthe pages 3-4
2. agola2011rabgtpasesas pages 2-3
3. wang2024anovelliquidliquid pages 13-16
4. kawatashimamura2022biomarkerdiscoveryfor pages 7-10
5. kitagishi2013rufyraband pages 7-9
6. bhuin2014rabproteinsthe pages 4-5
7. rahajeng2010importantrelationshipsbetween pages 4-6
8. https://doi.org/10.1016/j.yexcr.2014.07.027
9. https://doi.org/10.1111/j.1399-0004.2011.01724.x
10. https://doi.org/10.1091/mbc.E05-03-0204
11. https://doi.org/10.3389/fimmu.2024.1514613
12. https://doi.org/10.1186/s12885-022-09853-1
13. https://doi.org/10.3390/ijms14036487
14. https://doi.org/10.1111/j.1399-0004.2011.01724.x;
15. https://doi.org/10.4331/wjbc.v1.i8.254;
16. https://doi.org/10.3389/fimmu.2024.1514613;
17. https://doi.org/10.4331/wjbc.v1.i8.254
18. https://doi.org/10.1016/j.yexcr.2014.07.027,
19. https://doi.org/10.1111/j.1399-0004.2011.01724.x,
20. https://doi.org/10.1091/mbc.e05-03-0204,
21. https://doi.org/10.3389/fimmu.2024.1514613,
22. https://doi.org/10.1186/s12885-022-09853-1,
23. https://doi.org/10.3390/ijms14036487,
24. https://doi.org/10.4331/wjbc.v1.i8.254,

Overview of RAB15 (Ras-related Protein Rab-15) in Human Cells

RAB15 is a member of the small GTPase Rab family, which belongs to the Ras superfamily of regulatory proteins. Like other Rab GTPases, RAB15 is a molecular switch that cycles between an inactive GDP-bound state and an active GTP-bound state, thereby controlling various steps of intracellular membrane trafficking (www.reactome.org). In its GTP-bound form, RAB15 can recruit specific effector proteins to membranes, directing processes such as vesicle formation, movement along cytoskeletal tracks, and membrane tethering/fusion (www.reactome.org). This GTPase activity (EC 3.6.5.2) allows RAB15 to hydrolyze GTP and switch to the GDP-bound state, a cycle tightly regulated by accessory factors: guanine nucleotide exchange factors (GEFs) that activate Rab15 by promoting GDP–GTP exchange, GTPase-activating proteins (GAPs) that accelerate GTP hydrolysis, and GDP dissociation inhibitors (GDIs) that sequester the inactive Rab in the cytosol (www.reactome.org). RAB15 is a ~212 amino acid protein with a conserved P-loop NTP-binding domain characteristic of Ras-like GTPases. It undergoes post-translational prenylation at C-terminal cysteine residues (a hallmark of Rab proteins) which anchors it to cellular membranes (pmc.ncbi.nlm.nih.gov).

Gene and Expression: The RAB15 gene (UniProt P59190) is expressed in Homo sapiens and was first noted as a brain-enriched Rab protein. Early studies in rat identified Rab15 as a low molecular weight GTP-binding protein predominantly expressed in the brain (www.nature.com). Consistently, human RAB15 shows high expression in neural tissues, suggesting specialized roles in neurons. Notably, alternative splicing of the RAB15 transcript produces distinct isoforms. In neuroblastoma cells, two isoforms have been described: a 212-amino acid form termed Rab15CN, which includes all 7 exons and is primarily expressed in brain, and a slightly shorter isoform Rab15AN (208 amino acids) generated by skipping exon 4, predominantly expressed in testis (pubmed.ncbi.nlm.nih.gov). Intriguingly, retinoic acid-induced differentiation of neuroblastoma cells specifically upregulates the Rab15CN isoform and favors differentiation in cells expressing Rab15CN over those expressing Rab15AN (pubmed.ncbi.nlm.nih.gov). These findings suggest that Rab15CN may be the functionally relevant form in neurons, and RAB15 expression correlates with neuronal differentiation status (pubmed.ncbi.nlm.nih.gov). Outside the brain, RAB15 is expressed at lower levels in various tissues, and large-scale RNA analyses indicate it is not among the most ubiquitously expressed Rabs (which are Rab5, Rab7, etc.), underscoring a more cell-type specific role.

Cellular Localization: Within the cell, RAB15 is primarily associated with endosomal membranes. It localizes to early/sorting endosomes and the perinuclear recycling endosome compartment (pmc.ncbi.nlm.nih.gov) (www.nature.com). In cultured cells (e.g. CHO and HeLa cells), epitope-tagged Rab15 co-localizes with markers of early endosomes (such as Rab5 and early endosome antigen 1, EEA1) and with Rab4 on sorting endosomes, as well as with Rab11 on the endocytic recycling compartment (ERC) (www.nature.com). This distribution implies that Rab15 participates in endocytic sorting and in recycling of internalized cargo back to the plasma membrane. RAB15 has also been detected in the perinuclear region of the cytoplasm, consistent with localization to the ERC, which often surrounds the microtubule-organizing center (www.ncbi.nlm.nih.gov). Some data even suggest RAB15 might localize to primary cilia or related membranes (www.ncbi.nlm.nih.gov), although its function in ciliary trafficking is not well characterized. In neurons, given the high expression in brain, Rab15 is believed to be present on neuronal endosomal compartments and possibly synaptic vesicle recycling pools. Indeed, by sequence homology, it has been proposed that Rab15 may act in concert with Rab3A (a synaptic vesicle-associated Rab) to regulate membrane flow at nerve terminals (www.reactome.org), although direct experimental evidence for Rab15’s role in synapses is limited.

Biological Function – Role in Endocytosis and Recycling: RAB15 is a key regulator of the endocytic recycling pathway, which returns internalized receptors and membrane components back to the cell surface. Classic studies by Zuk and Elferink were among the first to elucidate Rab15’s function in endosomes. In Chinese hamster ovary (CHO) cells, overexpression of wild-type or GTPase-deficient (constitutively active) Rab15 was found to inhibit early endocytic uptake of cargo. Specifically, GTP-bound Rab15 (e.g. the Q67L mutant that locks Rab15 in an active state) reduced both fluid-phase and receptor-mediated endocytosis without altering the overall recycling rate of transferrin receptors from early endosomes (pubmed.ncbi.nlm.nih.gov). This suggested that active Rab15 puts a “brake” on the initial phase of endosome formation or fusion. Indeed, Rab15 activity was shown to slow the homotypic fusion of early endosomes, thereby delaying the maturation or enlargement of early endocytic vesicles (pubmed.ncbi.nlm.nih.gov). Conversely, the GDP-bound (inactive) form of Rab15 had the opposite effect. Cells expressing dominant-negative Rab15 mutants (such as T22N, which mimics the GDP-bound state, or N121I, a nucleotide-free mutant) showed enhanced endocytic uptake and accelerated fusion of early endosomes (pubmed.ncbi.nlm.nih.gov). In other words, inactivating Rab15 releases the brake, allowing endocytosis to proceed more rapidly. Notably, the inactive Rab15 mutants also caused changes in the recycling pathway – they differentially affected the transit of cargo through sorting vs. recycling endosomes, in some cases impairing the normal return of receptors to the surface (pubmed.ncbi.nlm.nih.gov). These combined data led researchers to conclude that Rab15 antagonizes the function of Rab5, the master regulator of early endosome fusion. Rab5 normally accelerates vesicle fusion and cargo sorting in the early endocytic pathway, and Rab15 appears to counteract this, preventing excessive or premature fusion (pubmed.ncbi.nlm.nih.gov). Supporting this model, constitutively active Rab15 was shown to attenuate Rab5-driven endosome fusion and endocytosis, whereas a GDP-locked Rab15 enhanced the effects of active Rab5 (pubmed.ncbi.nlm.nih.gov). Thus, Rab15 serves as a modulator of early endosomal dynamics, ensuring a balanced rate of cargo internalization and progression through the endosomal system.

Importantly, RAB15’s role is not limited to the early endosome; it also functions at later stages of the recycling route. The endocytic recycling compartment (ERC), marked by Rab11, is the station for “slow” recycling whereby internalized receptors can be stored and later returned to the membrane. Rab15 is one of the few Rabs that localize to both sorting endosomes and the ERC, suggesting it helps coordinate traffic between these connected stages (www.nature.com). In fact, Rab15 has been implicated in both the “fast” recycling route (direct return from sorting endosomes, which typically involves Rab4/Rab5) and the “slow” recycling route (via Rab11-positive ERC) (pmc.ncbi.nlm.nih.gov). A 2011 review noted that after endocytosis, some receptors recycle rapidly with Rab4, Rab14, and Rab15 on sorting endosomes, while others take a slower route through Rab11/Rab15 compartments (pmc.ncbi.nlm.nih.gov). This dual presence indicates RAB15 might regulate the decision or transition between these two recycling pathways.

Rab15 Effector – REP15 and Mechanistic Insights: Like other Rab GTPases, Rab15 exerts its effects by recruiting effector proteins that execute trafficking steps. A major advance in understanding Rab15 came with the discovery of a specific effector, named Rab15 Effector Protein (REP15), by Strick and Elferink (2005). REP15 was identified via yeast two-hybrid and co-immunoprecipitation as a protein that binds directly to GTP-bound Rab15 (pmc.ncbi.nlm.nih.gov). Notably, REP15 localizes selectively to the endocytic recycling compartment: it co-localizes with Rab15 and Rab11 in the perinuclear ERC, but is absent from early sorting endosomes (pmc.ncbi.nlm.nih.gov). In other words, REP15 associates with Rab15 only on the recycling endosome subpopulation, not on the initial early endosomes. Mechanistically, REP15 appears to mediate the “slow” recycling of receptors from the ERC to the plasma membrane. When REP15 levels are manipulated, there are specific effects on receptor trafficking: overexpression or siRNA knockdown of REP15 both inhibit transferrin receptor recycling from the ERC, without affecting the initial internalization of transferrin or its rapid recycling from sorting endosomes (pmc.ncbi.nlm.nih.gov). This result indicates that REP15 is required for the efficient exit of cargo from the ERC (a slower phase of recycling), while Rab15 likely uses other effectors for earlier stages. The recruitment of REP15 by Rab15-GTP thus provides a molecular mechanism for how Rab15 controls the slow recycling pathway. It “gates” the release of receptors from the ERC, possibly by organizing vesicle budding or tethering events specific to that compartment (pmc.ncbi.nlm.nih.gov). Overall, Rab15 differentially regulates transferrin receptor trafficking through sorting endosomes vs. the ERC by engaging distinct effectors at each station (pmc.ncbi.nlm.nih.gov). The discovery of REP15 underscored that RAB15’s function is compartment-specific: the same Rab protein can have multiple roles depending on which effector it binds and where.

Beyond REP15, emerging evidence suggests Rab15 can interact with a broader network of effectors, some of which are shared with other Rabs. A recent study characterized Rep15’s structure and interactions and also noted that Rab15 binds a set of bMERB domain proteins (www.nature.com) (www.nature.com). These include MICAL1, MICAL3, MICAL-cL, EHBP1, and EHBP1L1 – factors known to link Rab GTPases to actin cytoskeleton remodeling and membrane tubulation (www.nature.com). Interestingly, MICAL and EHBP1 family members are typically effectors for Rab8/Rab10 involved in recycling and cytoskeletal dynamics (www.nature.com). The finding that Rab15 can also recruit these effectors suggests functional overlap or crosstalk between Rab15 and other Rabs in coordinating endosome-to-membrane transport. The exact functional significance of Rab15’s interaction with bMERB-domain effectors remains to be fully elucidated (www.nature.com). One hypothesis is that Rab15, perhaps in its sorting-endosome locale, might influence actin or membrane tubule formation to regulate sorting decisions (for example, determining which tubules go back to the surface vs. to the Golgi or remain endosomal). Further structural analysis in 2022 provided high-resolution insight into Rab15-effector binding: Rep15 was crystallized in complex with Rab3 isoforms, revealing a unique globular fold distinct from other known Rab effector complexes (www.nature.com). These structural studies confirmed that Rep15 binds Rab15 in a 1:1 stoichiometry with high affinity and clarified how Rep15 recognizes Rab15 versus other Rabs (www.nature.com). Interestingly, Rep15 turned out capable of binding not only Rab15 but also certain Rab3 paralogs and Rab34, though it does not bind Rab5 or Rab11 (pmc.ncbi.nlm.nih.gov) (www.nature.com). Mutational analysis pinpointed key amino acids that confer this specificity (www.nature.com). Such data expand our understanding of the Rab15 interactome and suggest that RAB15 might function in concert with other Rabs (Rab3, Rab34) in specific cell contexts, possibly linking endosomal recycling with secretory vesicle pools or lysosomal pathways.

Physiological and Pathway Context: The primary pathway regulated by Rab15 is the endocytic recycling pathway, which is crucial for maintaining cell surface homeostasis. For example, the transferrin receptor (TfR) – which mediates iron uptake – continuously cycles between the plasma membrane and endosomes. Rab15 helps control the rate and route of TfR recycling (pmc.ncbi.nlm.nih.gov). Under normal conditions, a portion of internalized TfR rapidly returns to the membrane directly from early endosomes (fast route), while another portion is delivered to the ERC and recycled more slowly (slow route). By engaging different effectors at early endosomes vs. the ERC, Rab15 can bias trafficking toward one route or modulate the timing. This ensures, for instance, that receptors are not recycled too quickly (which could lead to uncontrolled signaling or uptake) and that endosomes have adequate time for sorting. Rab15’s “brake” on early endosome fusion likely prevents excessive enlargement or premature transition to late endosomes, maintaining a proper sorting compartment for receptors (pubmed.ncbi.nlm.nih.gov). In cells where Rab15 is absent or inactive, Rab5-driven early fusion predominates, potentially accelerating cargo degradation or mis-sorting. Thus, Rab15 contributes to the fidelity of cargo recycling versus degradation.

There is also evidence that Rab15’s regulation of endosome dynamics has implications for other cellular pathways like autophagy and pathogen defense. Autophagy, particularly the maturation of autophagosomes into degradative autolysosomes, intersects with endocytic trafficking. Recent studies (2023–2024) indicate that Rab15 can act as a negative regulator of autophagy by restraining endosome maturation. Specifically, depletion of RAB15 was found to promote the maturation of early endosomes into late endosomes that fuse with lysosomes, thereby enhancing autophagic flux (pmc.ncbi.nlm.nih.gov). Conversely, when Rab15 is active, early endosomal compartments are prolonged and their fusion with lysosomes is inhibited, which tends to slow autophagic degradation of cargo (pmc.ncbi.nlm.nih.gov). This phenomenon has been observed in the context of intracellular bacterial infection. For example, the bacterium Ehrlichia chaffeensis hijacks the host cell’s endosomal system to create a protective niche (an Ehrlichia-containing vacuole, ECV). A 2024 study showed that Ehrlichia secretes an effector (Etf-3) that specifically upregulates host RAB15 expression, leading to increased Rab15 on the ECV membrane (www.mdpi.com) (www.mdpi.com). Rab15 enrichment on these vacuoles prevents their fusion with RAB7-positive late endosomes/lysosomes and at the same time induces an autophagy-like environment around the vacuole (www.mdpi.com) (www.mdpi.com). When RAB15 was silenced by siRNA in infected cells, the ECVs more readily acquired late endosomal markers (like RAB7 and mannose-6-phosphate receptor) and fused with lysosomes, resulting in clearance of the bacteria (www.mdpi.com) (www.mdpi.com). Moreover, Rab15 knockdown abolished the accumulation of LC3-II (an autophagosome marker) normally seen during infection (www.mdpi.com), indicating that Rab15 was required for the pro-autophagic response to infection. In sum, Rab15 helps the pathogen by keeping its vacuole in an “early” state and promoting autophagy initiation (perhaps to supply nutrients) without completion of degradation (pmc.ncbi.nlm.nih.gov) (www.mdpi.com). This is a striking example of how Rab15’s role in endosome maturation has broader consequences: it can be subverted by pathogens to evade destruction. The Ehrlichia study not only shed light on host-pathogen interaction but also reinforced that Rab15 is a critical node controlling the balance between recycling/sorting vs. degradation in the endolysosomal system (www.mdpi.com) (www.mdpi.com). These recent findings expand our understanding of Rab15’s function beyond “housekeeping” receptor recycling, showing it can influence autophagic flux and immune defense.

Current Developments and Applications: While RAB15 is not as extensively studied as some other Rab proteins, there is growing interest in its potential roles in health and disease. Dysregulation of membrane trafficking is a feature of many diseases (neurodegenerative disorders, infections, and cancer), and RAB proteins are increasingly recognized in these contexts (pmc.ncbi.nlm.nih.gov). A broad review in 2011 noted that Rab GTPases are implicated in various human diseases but remain underexplored therapeutically, meaning few drugs target Rab pathways despite their importance (pmc.ncbi.nlm.nih.gov). RAB15, in particular, has been associated with a few pathological and clinical scenarios:

• Cancer: Large-scale analyses have found that RAB15 expression is altered in certain cancers. For example, a 2022 transcriptomic study of colorectal cancer (CRC) reported RAB15 among a subset of RAB genes that are significantly upregulated in tumor tissues compared to normal colon epithelium (www.frontiersin.org). In that study, seven RABs (including RAB10, RAB11A, RAB15, RAB17, etc.) were consistently over-expressed in colorectal tumors (www.frontiersin.org). High RAB15 expression in tumors might reflect the cancer cells’ increased demand for membrane recycling (to support rapid growth and nutrient uptake), or it could influence how cancer cells modulate their surface receptors. Some Rabs are known to affect cancer cell migration and invasion by regulating integrin and growth factor receptor trafficking (pmc.ncbi.nlm.nih.gov), though RAB15’s specific impact in cancer cells is not yet well defined. Notably, the Rab15 effector REP15 has also emerged in cancer genomics: a 2020 multi-omics analysis identified REP15 as a potential driver gene in colorectal cancer (www.nature.com). While REP15’s exact contribution to tumor biology needs clarification, its involvement suggests that Rab15-regulated recycling pathways could affect cancer cell behavior, possibly by controlling receptor availability (e.g., nutrient receptors, immune checkpoint molecules, etc.) on the cell surface. These insights are spurring further research into whether Rab15 or its effectors can serve as prognostic markers or therapeutic targets in oncology.

• Neurobiology: Given its enrichment in the brain, Rab15 may be relevant to neurological function or development. The correlation of Rab15CN isoform with neuronal differentiation (via retinoic acid in neuroblastoma models) suggests Rab15 could play a role in neurite outgrowth or synaptic maturation. There is no well-established monogenic disorder of RAB15 in humans, but one could speculate that aberrant Rab15 function might impact synaptic vesicle recycling or receptor trafficking in neurons. Future studies are needed to explore Rab15’s role in neurodegenerative diseases or cognitive function. Interestingly, some in vitro data indicate Rab15 can influence the trafficking of the β-amyloid precursor protein (APP) or other receptors in neurons (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov) (though RAB5 and RAB11 are more prominently linked to Alzheimer’s pathways).

• Immunology and Infection: The example of E. chaffeensis exploiting Rab15 to avoid lysosomal destruction highlights Rab15 as a factor in intracellular infections (www.mdpi.com) (www.mdpi.com). It also raises the idea that modulating RAB15 activity might be a therapeutic strategy to enhance clearance of certain pathogens. By inhibiting Rab15 or its upregulation, one might force pathogenic vacuoles to mature and fuse with lysosomes. However, such interventions would need to be balanced, as blocking Rab15 broadly could disrupt normal recycling processes in host cells. To date, no Rab15-specific inhibitors exist, but this is an area for potential drug development. More generally, Rabs like Rab15 represent attractive drug targets or diagnostic markers because they sit at crucial junctions of cellular trafficking routes (pmc.ncbi.nlm.nih.gov).

Expert Perspectives: Authoritative reviews consider Rab15 as part of the cellular trafficking network that is often co-opted in disease. A clinical genetics review (Agola et al., 2011) summarized that Rab15 localizes to early and recycling endosomes, mediating trafficking from sorting endosomes back to the plasma membrane (pmc.ncbi.nlm.nih.gov). Unlike some Rabs, Rab15 has not been directly linked to a defined genetic disorder, but experts emphasize that many Rab GTPases (and their regulators) contribute to organ-specific diseases when mutated or misregulated (pmc.ncbi.nlm.nih.gov). For instance, other Rab-family members are known oncogenes or tumor suppressors, and some cause Mendelian syndromes when mutated (e.g., Rab27 in Griscelli syndrome). While Rab15 itself is not yet in that category, its regulatory role in endocytosis could influence phenomena like cell migration or nutrient uptake, which are central to cancer metastasis and metabolic diseases. Thus, researchers posit that understanding Rab15’s interactome and regulation could yield new insights into controlling cell surface receptor levels — an area relevant to conditions like insulin resistance or cancer cell immune evasion. Indeed, the 2022 CRC study suggested that patterns of RAB protein expression (including RAB15) might predict tumor subtype and even immunotherapy responsiveness (www.frontiersin.org) (www.frontiersin.org). High RAB15 expression was associated with the “CMS3” subtype of colorectal cancer, which has distinct metabolic features and frequent RAS mutations (www.frontiersin.org) (www.frontiersin.org). Although RAB15 is not directly targetable today, such findings point to RAB15 as part of a signature that could inform prognosis or treatment stratification.

In summary, RAB15 is a specialized Rab GTPase that regulates early endosome dynamics and the recycling of membrane receptors. It acts as a molecular switch on endosomal membranes, recruiting different effectors to coordinate “fast” vs “slow” recycling routes back to the cell surface. By counterbalancing Rab5, Rab15 fine-tunes the rate of endocytic uptake and prevents unchecked progression to degradation, thereby preserving a pool of recycling receptors. Its function is exemplified in transferrin receptor trafficking and is critical for maintaining cellular iron homeostasis (pmc.ncbi.nlm.nih.gov). Emerging research has expanded Rab15’s relevance to include roles in autophagy and pathogen survival, as well as potential implications in cancer cell physiology. These insights come from both recent primary studies (2023–2024) and expert analyses, reflecting a current understanding that Rab15, though once relatively obscure, is an important node in the membrane trafficking network with connections to human health. Ongoing studies are likely to further elucidate its regulation (e.g. identifying its GEFs/GAPs) and how its dysfunction may contribute to disease. Given that membrane trafficking is fundamental to processes like nutrient uptake, receptor signaling, and antigen presentation, Rab15 and its pathway could become targets of interest for therapeutic intervention or biomarkers for diseases where cell surface receptor recycling is disrupted. Future research will continue to clarify the precise molecular mechanisms of Rab15 and how this small GTPase can be manipulated to benefit human health.

References:

• Elferink LA et al. (1992). J. Biol. Chem. 267(8):5768-5775. (Discovery of Rab15 as a brain-specific GTP-binding protein)
• Zuk PA & Elferink LA. (1999). J. Biol. Chem. 274(32):22303-22312. (Rab15 localization and role in CHO cell endocytosis) (www.nature.com) (www.reactome.org)
• Zuk PA & Elferink LA. (2000). J. Biol. Chem. 275(35):26754-26764. (Functional analysis of Rab15 mutants in endocytic trafficking) (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov) (Published Aug 2000)
• Strick DJ & Elferink LA. (2005). Mol. Biol. Cell 16(12):5699-5709. (Identification of REP15 and its role in transferrin recycling) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov) (Published Dec 2005)
• Agola JO et al. (2011). Clin. Genet. 80(4):305-318. (Rab GTPases in endocytosis and disease) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov) (Published Oct 2011)
• Banworth MJ & Li G. (2017). Small GTPases 9(1-2):158-181. (Rab dysfunction in human diseases)
• Pham TV et al. (2012). Oncol. Rep. 27(6):2045-2049. (Rab15 alternative splicing in neuroblastoma; RA-induced differentiation findings) (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov) (Published 2012)
• Rai A et al. (2016). eLife 5:e18675. (bMERB domain Rab8-family effectors; noted Rab15 interactions)
• Rai A et al. (2020). Nat. Commun. 11:4187. (Rab8 activation of EHBP1; context for Rab15-effector studies)
• Xu X et al. (2020). Epigenomics 12(19):1633-1650. (Multi-omics identifies REP15 as CRC driver)
• Jiang X et al. (2022). Front. Genet. 13:828373. (Rab GTPases expression in colorectal cancer and immunotherapy response) (www.frontiersin.org) (Published Jan 28, 2022)
• Chava KR et al. (2022). Nature Commun. 13:4447. (Structural characterization of Rep15 and Rab15/Rab3/Rab34 interactions) (www.nature.com) (www.nature.com) (Published Aug 2022)
• Yang N et al. (2024). Int. J. Mol. Sci. 25(5):2551. (Ehrlichia effector upregulates Rab15 to inhibit lysosome fusion and induce autophagy) (www.mdpi.com) (www.mdpi.com) (Published Feb 22, 2024)
• Abba R & Colombo MI. (2025). Biochem. J. 482(20):1531–1544. (Rab GTPases in autophagy; notes Rab15 as negative regulator of autophagosome maturation) (pmc.ncbi.nlm.nih.gov) (Published Oct 17, 2025)

Citations

1. AnnotationURLCitation(end_index=525, start_index=389, title='Reactome | UniProt:P59190 RAB15', type='url_citation', url='https://www.reactome.org/content/schema/instance/browser/uniprot%3AP59190#:~:text=,GEFs%29%20which%20promote%20the')
2. AnnotationURLCitation(end_index=862, start_index=726, title='Reactome | UniProt:P59190 RAB15', type='url_citation', url='https://www.reactome.org/content/schema/instance/browser/uniprot%3AP59190#:~:text=,GEFs%29%20which%20promote%20the')
3. AnnotationURLCitation(end_index=1453, start_index=1269, title='Reactome | UniProt:P59190 RAB15', type='url_citation', url='https://www.reactome.org/content/schema/instance/browser/uniprot%3AP59190#:~:text=tethering%20and%20fusion%20%28By%20similarity%29,GTP%20bound%20form%20of%20RAB15')
4. AnnotationURLCitation(end_index=1865, start_index=1713, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab14%20%20,induced%20apoptosis%3B%20phagosome%20acidification%20and')
5. AnnotationURLCitation(end_index=2271, start_index=2133, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rab15%20is%20enriched%20explicitly%20in,cL%2C%20EHBP1%20and')
6. AnnotationURLCitation(end_index=2932, start_index=2756, title='Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21491086/#:~:text=spliced%20Rab15%20isoforms%20designated%20as,induced%20differentiation%20of%20newly%20established')
7. AnnotationURLCitation(end_index=3321, start_index=3141, title='Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21491086/#:~:text=RA%20induced%20neuronal%20differentiation%20of,induced%20differentiation%20of%20neuroblastoma%20cells')
8. AnnotationURLCitation(end_index=3658, start_index=3478, title='Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21491086/#:~:text=RA%20induced%20neuronal%20differentiation%20of,induced%20differentiation%20of%20neuroblastoma%20cells')
9. AnnotationURLCitation(end_index=4256, start_index=4104, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab14%20%20,induced%20apoptosis%3B%20phagosome%20acidification%20and')
10. AnnotationURLCitation(end_index=4418, start_index=4257, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rab15%20is%20enriched%20explicitly%20in,additional%20studies%20are%20required%20to')
11. AnnotationURLCitation(end_index=4845, start_index=4684, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rab15%20is%20enriched%20explicitly%20in,additional%20studies%20are%20required%20to')
12. AnnotationURLCitation(end_index=5318, start_index=5162, title='RAB15 RAB15, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/376267#:~:text=Summary%20Enables%20G%20protein%20activity,provided%20by%20Alliance%20of%20Genome')
13. AnnotationURLCitation(end_index=5560, start_index=5404, title='RAB15 RAB15, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/376267#:~:text=Summary%20Enables%20G%20protein%20activity,provided%20by%20Alliance%20of%20Genome')
14. AnnotationURLCitation(end_index=6121, start_index=5973, title='Reactome | UniProt:P59190 RAB15', type='url_citation', url='https://www.reactome.org/content/schema/instance/browser/uniprot%3AP59190#:~:text=active%20GTP,GTP%20bound%20form%20of%20RAB15')
15. AnnotationURLCitation(end_index=7079, start_index=6933, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=Rab%20GTPases%20play%20an%20important,be%20due%20to%20a%20reduction')
16. AnnotationURLCitation(end_index=7487, start_index=7344, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=in%20the%20rate%20of%20homotypic,effect%20of%20Rab5%20on%20early')
17. AnnotationURLCitation(end_index=7921, start_index=7778, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=in%20the%20rate%20of%20homotypic,effect%20of%20Rab5%20on%20early')
18. AnnotationURLCitation(end_index=8415, start_index=8272, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=in%20the%20rate%20of%20homotypic,effect%20of%20Rab5%20on%20early')
19. AnnotationURLCitation(end_index=8912, start_index=8731, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=that%20HArab15%20may%20counteract%20the,early%2Fsorting%20and%20pericentriolar%20recycling%20endosomes')
20. AnnotationURLCitation(end_index=9279, start_index=9098, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=that%20HArab15%20may%20counteract%20the,early%2Fsorting%20and%20pericentriolar%20recycling%20endosomes')
21. AnnotationURLCitation(end_index=10057, start_index=9896, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rab15%20is%20enriched%20explicitly%20in,additional%20studies%20are%20required%20to')
22. AnnotationURLCitation(end_index=10434, start_index=10268, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=early%20endosome%20segregates%20molecules%20for,as%20well%20as%20for%20degradation')
23. AnnotationURLCitation(end_index=10797, start_index=10631, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=early%20endosome%20segregates%20molecules%20for,as%20well%20as%20for%20degradation')
24. AnnotationURLCitation(end_index=11507, start_index=11366, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=protein%20,recycling%20from%20the%20endocytic%20recycling')
25. AnnotationURLCitation(end_index=11839, start_index=11698, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=protein%20,recycling%20from%20the%20endocytic%20recycling')
26. AnnotationURLCitation(end_index=12572, start_index=12383, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=Consistent%20with%20its%20localization%2C%20REP15,recycling%20are%20mechanistically%20distinct%20pathways')
27. AnnotationURLCitation(end_index=13207, start_index=13018, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=Consistent%20with%20its%20localization%2C%20REP15,recycling%20are%20mechanistically%20distinct%20pathways')
28. AnnotationURLCitation(end_index=13549, start_index=13371, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=previously%20reported%20that%20Rab15%20differentially,the%20novel%20protein%20Rab15%20effector')
29. AnnotationURLCitation(end_index=14124, start_index=14000, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=we%20have%20shown%20that%20Rab15,Apart%20from')
30. AnnotationURLCitation(end_index=14285, start_index=14125, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=that%20it%20has%20distinct%20roles,Rab15%20effector%20molecule%20that%20regulates')
31. AnnotationURLCitation(end_index=14603, start_index=14443, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=that%20it%20has%20distinct%20roles,Rab15%20effector%20molecule%20that%20regulates')
32. AnnotationURLCitation(end_index=14898, start_index=14738, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=that%20it%20has%20distinct%20roles,Rab15%20effector%20molecule%20that%20regulates')
33. AnnotationURLCitation(end_index=15354, start_index=15194, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=that%20it%20has%20distinct%20roles,Rab15%20effector%20molecule%20that%20regulates')
34. AnnotationURLCitation(end_index=15978, start_index=15843, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=In%20their%20GTP,structure%20that%20is%20distinct%20from')
35. AnnotationURLCitation(end_index=16301, start_index=16143, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rep15%20forms%20a%20stable%20complex,binding%20mode%2C%20we%20have%20determined')
36. AnnotationURLCitation(end_index=16594, start_index=16453, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=protein%20,recycling%20from%20the%20endocytic%20recycling')
37. AnnotationURLCitation(end_index=16753, start_index=16595, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rep15%20forms%20a%20stable%20complex,binding%20mode%2C%20we%20have%20determined')
38. AnnotationURLCitation(end_index=17003, start_index=16831, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=interaction%20partners%20and%20further%20validated,binding%20mode%2C%20we%20have%20determined')
39. AnnotationURLCitation(end_index=17825, start_index=17636, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=Consistent%20with%20its%20localization%2C%20REP15,recycling%20are%20mechanistically%20distinct%20pathways')
40. AnnotationURLCitation(end_index=18715, start_index=18534, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=that%20HArab15%20may%20counteract%20the,early%2Fsorting%20and%20pericentriolar%20recycling%20endosomes')
41. AnnotationURLCitation(end_index=19615, start_index=19526, title='Vesicular transport in the autophagic route: RAB GTPases as pivotal regulators of autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12687433/#:~:text=,111')
42. AnnotationURLCitation(end_index=19881, start_index=19792, title='Vesicular transport in the autophagic route: RAB GTPases as pivotal regulators of autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12687433/#:~:text=,111')
43. AnnotationURLCitation(end_index=20424, start_index=20299, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=%28T4SS%29%20effector%20Etf,chaffeensis%20using%20confocal')
44. AnnotationURLCitation(end_index=20517, start_index=20425, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=2,chaffeensis%20Infection')
45. AnnotationURLCitation(end_index=20831, start_index=20706, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=%28T4SS%29%20effector%20Etf,chaffeensis%20using%20confocal')
46. AnnotationURLCitation(end_index=20949, start_index=20832, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=RAB15%3B%20type%20IV%20secretion%20system,effector')
47. AnnotationURLCitation(end_index=21256, start_index=21167, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=microscopy,chaffeensis')
48. AnnotationURLCitation(end_index=21379, start_index=21257, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=localized%20on%20lysosomes%20,1%20cells%20compared%20to')
49. AnnotationURLCitation(end_index=21607, start_index=21501, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=whether%20RAB15%20is%20involved%20in,We')
50. AnnotationURLCitation(end_index=22002, start_index=21869, title='Vesicular transport in the autophagic route: RAB GTPases as pivotal regulators of autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12687433/#:~:text=depletion%20promotes%20the%20maturation%20of,102')
51. AnnotationURLCitation(end_index=22092, start_index=22003, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=microscopy,chaffeensis')
52. AnnotationURLCitation(end_index=22547, start_index=22458, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=microscopy,chaffeensis')
53. AnnotationURLCitation(end_index=22670, start_index=22548, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=localized%20on%20lysosomes%20,1%20cells%20compared%20to')
54. AnnotationURLCitation(end_index=23357, start_index=23222, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab%20GTPases%20are%20well,The%20broad%20range%20of')
55. AnnotationURLCitation(end_index=23688, start_index=23553, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab%20GTPases%20are%20well,The%20broad%20range%20of')
56. AnnotationURLCitation(end_index=24260, start_index=24085, title='Frontiers | The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer', type='url_citation', url='https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.828373/full#:~:text=Results%3A%20Of%20the%2062%20RABs,RABs%2C%20which%20were')
57. AnnotationURLCitation(end_index=24567, start_index=24392, title='Frontiers | The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer', type='url_citation', url='https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.828373/full#:~:text=Results%3A%20Of%20the%2062%20RABs,RABs%2C%20which%20were')
58. AnnotationURLCitation(end_index=25031, start_index=24920, title='Consequences of Rab GTPase dysfunction in genetic or acquired human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5902184/#:~:text=diseases%20,231%20and%20PC3')
59. AnnotationURLCitation(end_index=25425, start_index=25273, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=bMERB%20family%20members%2C%20Rep15%20is,depletion%20of%20Rep15%20by%20si')
60. AnnotationURLCitation(end_index=26763, start_index=26642, title='Consequences of Rab GTPase dysfunction in genetic or acquired human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5902184/#:~:text=Marcellus%20J%20Banworth%20,%E2%9C%89')
61. AnnotationURLCitation(end_index=26874, start_index=26764, title='Consequences of Rab GTPase dysfunction in genetic or acquired human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5902184/#:~:text=Skip%20to%20main%20content')
62. AnnotationURLCitation(end_index=27247, start_index=27122, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=%28T4SS%29%20effector%20Etf,chaffeensis%20using%20confocal')
63. AnnotationURLCitation(end_index=27337, start_index=27248, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=microscopy,chaffeensis')
64. AnnotationURLCitation(end_index=28111, start_index=27976, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab%20GTPases%20are%20well,The%20broad%20range%20of')
65. AnnotationURLCitation(end_index=28600, start_index=28448, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab14%20%20,induced%20apoptosis%3B%20phagosome%20acidification%20and')
66. AnnotationURLCitation(end_index=28957, start_index=28822, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab%20GTPases%20are%20well,The%20broad%20range%20of')
67. AnnotationURLCitation(end_index=29898, start_index=29735, title='Frontiers | The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer', type='url_citation', url='https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.828373/full#:~:text=,vitro%20experiments%20showed%20that%20RAB17')
68. AnnotationURLCitation(end_index=30087, start_index=29899, title='Frontiers | The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer', type='url_citation', url='https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.828373/full#:~:text=cell%20cycle%20and%20immune,and%20immunotherapy%20response%20in%20CRC')
69. AnnotationURLCitation(end_index=30428, start_index=30237, title='Frontiers | The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer', type='url_citation', url='https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.828373/full#:~:text=match%20at%20L311%20analysis%20in,test.%20%28C%E2%80%93D%29%20Gene%20set')
70. AnnotationURLCitation(end_index=30624, start_index=30429, title='Frontiers | The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer', type='url_citation', url='https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.828373/full#:~:text=curves%20of%20the%20upregulated,RAB12%2C%20RAB23%2C%20RAB31%2C%20and%20RAB34')
71. AnnotationURLCitation(end_index=31560, start_index=31371, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=Consistent%20with%20its%20localization%2C%20REP15,recycling%20are%20mechanistically%20distinct%20pathways')
72. AnnotationURLCitation(end_index=33014, start_index=32853, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rab15%20is%20enriched%20explicitly%20in,additional%20studies%20are%20required%20to')
73. AnnotationURLCitation(end_index=33163, start_index=33015, title='Reactome | UniProt:P59190 RAB15', type='url_citation', url='https://www.reactome.org/content/schema/instance/browser/uniprot%3AP59190#:~:text=active%20GTP,GTP%20bound%20form%20of%20RAB15')
74. AnnotationURLCitation(end_index=33443, start_index=33300, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=in%20the%20rate%20of%20homotypic,effect%20of%20Rab5%20on%20early')
75. AnnotationURLCitation(end_index=33625, start_index=33444, title='Rab15 differentially regulates early endocytic trafficking - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/10837464/#:~:text=that%20HArab15%20may%20counteract%20the,early%2Fsorting%20and%20pericentriolar%20recycling%20endosomes')
76. AnnotationURLCitation(end_index=33925, start_index=33784, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=protein%20,recycling%20from%20the%20endocytic%20recycling')
77. AnnotationURLCitation(end_index=34115, start_index=33926, title='Rab15 Effector Protein: A Novel Protein for Receptor Recycling from the Endocytic Recycling Compartment - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1289414/#:~:text=Consistent%20with%20its%20localization%2C%20REP15,recycling%20are%20mechanistically%20distinct%20pathways')
78. AnnotationURLCitation(end_index=34390, start_index=34238, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=Rab14%20%20,induced%20apoptosis%3B%20phagosome%20acidification%20and')
79. AnnotationURLCitation(end_index=34557, start_index=34391, title='Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/#:~:text=early%20endosome%20segregates%20molecules%20for,as%20well%20as%20for%20degradation')
80. AnnotationURLCitation(end_index=34998, start_index=34822, title='Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21491086/#:~:text=spliced%20Rab15%20isoforms%20designated%20as,induced%20differentiation%20of%20newly%20established')
81. AnnotationURLCitation(end_index=35179, start_index=34999, title='Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21491086/#:~:text=RA%20induced%20neuronal%20differentiation%20of,induced%20differentiation%20of%20neuroblastoma%20cells')
82. AnnotationURLCitation(end_index=35826, start_index=35651, title='Frontiers | The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer', type='url_citation', url='https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.828373/full#:~:text=Results%3A%20Of%20the%2062%20RABs,RABs%2C%20which%20were')
83. AnnotationURLCitation(end_index=36116, start_index=35981, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=In%20their%20GTP,structure%20that%20is%20distinct%20from')
84. AnnotationURLCitation(end_index=36257, start_index=36117, title='Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-022-31831-1#:~:text=Rab15%20is%20enriched%20explicitly%20in,14%7D%2C%20suggesting')
85. AnnotationURLCitation(end_index=36551, start_index=36426, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=%28T4SS%29%20effector%20Etf,chaffeensis%20using%20confocal')
86. AnnotationURLCitation(end_index=36641, start_index=36552, title='Ehrlichia chaffeensis Etf-3 Induces Host RAB15 Upregulation for Bacterial Intracellular Growth', type='url_citation', url='https://www.mdpi.com/1422-0067/25/5/2551#:~:text=microscopy,chaffeensis')
87. AnnotationURLCitation(end_index=36912, start_index=36823, title='Vesicular transport in the autophagic route: RAB GTPases as pivotal regulators of autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12687433/#:~:text=,111')